Results 61 to 70 of about 8,711 (288)

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

open access: yesMolecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen   +13 more
wiley   +1 more source

Peer instruction to address alternative conceptions in Einstein's special relativity

open access: yesRevista Brasileira de Ensino de Física
In education, decades have been spent investigating what kind of beliefs and attitudes students may have in relation to learning. The relevance of these lies on the implications that it brings concerning students' alternative conceptions.
Manuel S. Alvarez-Alvarado   +2 more
doaj   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Measuring Electromagnetic Fields in Rotating Frames of Reference

open access: yesUniverse, 2020
We review the problem of transforming electromagnetic fields between inertial and rotating reference frames. We compare the method of straightforward tensor coordinate transformations adopted by Schiff in his well-known paper of 1939 with the method of ...
Clive C. Speake, Antonello Ortolan
doaj   +1 more source

MET variants with activating N‐lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation

open access: yesMolecular Oncology, EarlyView.
MET variants in the N‐lobe of the kinase domain, found in hereditary papillary renal cell carcinoma, require ligand stimulation to promote cell transformation, in contrast to other RTK variants. This suggests that HGF expression in the microenvironment is important for tumor growth in such patients. Their sensitivity to MET inhibitors opens the way for
Célia Guérin   +14 more
wiley   +1 more source

Axion mass bound in very special relativity

open access: yesPhysics Letters B, 2017
In this paper we propose a very special relativity (VSR)-inspired description of the axion electrodynamics. This proposal is based upon the construction of a proper study of the SIM(2)–VSR gauge-symmetry.
R. Bufalo, S. Upadhyay
doaj   +1 more source

Is Einstein’s Special Relativity Wrong?

open access: yesSSRN Electronic Journal, 2020
Einstein’s special relativity is incomplete. It is vogue at the speed of the light and does not present a correct value of the momentum in the spacetime. Hence, all formulas that have been extracted in the last century should be reviewed.
Kalhor, Bahram   +2 more
openaire   +2 more sources

Plasma lipidomic and metabolomic profiles in high‐grade glioma patients before and after 72‐h presurgery water‐only fasting

open access: yesMolecular Oncology, EarlyView.
Presurgery 72‐h fasting in GB patients leads to adaptations of plasma lipids and polar metabolites. Fasting reduces lysophosphatidylcholines and increases free fatty acids, shifts triglycerides toward long‐chain TGs and increases branched‐chain amino acids, alpha aminobutyric acid, and uric acid.
Iris Divé   +7 more
wiley   +1 more source

Relative velocity premise in special relativity

open access: yes, 2023
Modification of Lorentz transformation into vector form with additional higher order terms.
openaire   +1 more source

Targeting the MDM2‐MDM4 interaction interface reveals an otherwise therapeutically active wild‐type p53 in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
This study investigates an alternative approach to reactivating the oncosuppressor p53 in cancer. A short peptide targeting the association of the two p53 inhibitors, MDM2 and MDM4, induces an otherwise therapeutically active p53 with unique features that promote cell death and potentially reduce toxicity towards proliferating nontumor cells.
Sonia Valentini   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy